Figure 2From: Contractile properties and movement behaviour in neonatal rats with axotomy, treated with the NMDA antagonist DAP5Muscle Weight. Muscle weight was reduced by crush, after P14 in EDL and after P21 in soleus (p < 0.01). DAP-5 increased muscle weight, but not to the level of control animals.Back to article page